So Michael Moore brought his latest film to Washington on June 20 for a well-publicized preview. “SiCKO” seemed to push most other serious health policy discussions off the agenda for the week, even while key congressional committees were voting on more than a dozen important health care bills on prescription drug safety and health spending.
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber












